Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib in Relapsed High-grade Osteosarcoma
NCT00889057Phase 2Completed
- Sponsor
- Italian Sarcoma Group
- Start
- Jan 2008
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in osteosarcoma (OS), sponsored by Italian Sarcoma Group. Started Jan 2008; status: completed.
02
Drugs
sorafenib
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on NCT00889057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00889057.